Glycoprotein IIb/IIIa Receptor Inhibition with Abciximab during Percutaneous Coronary Interventions Increases the Risk of Bleeding in Patients with Impaired Renal Function

Publisher: Karger

E-ISSN: 1421-9751|111|4|247-253

ISSN: 0008-6312

Source: Cardiology, Vol.111, Iss.4, 2008-04, pp. : 247-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content